Lipid Metabolism — MCQs

Lipid Metabolism Indian Medical PG Practice Questions and MCQs

Question 481: Lipoprotein X is most likely to be seen with which of the following conditions?

A. Cholestasis (Correct Answer)
B. Gilbert syndrome
C. Increased intake of trans fatty acids
D. Increased intake of polyunsaturated fatty acids

Explanation: **Explanation:** **Lipoprotein X (LpX)** is an abnormal, pathological lipoprotein that appears in the serum of patients with **cholestasis** (obstructive jaundice) or Lecithin-Cholesterol Acyltransferase (LCAT) deficiency. **Why Cholestasis is Correct:** In cholestasis, the normal biliary excretion of phospholipids and cholesterol is impaired. This leads to a "regurgitation" of biliary lipids into the plasma. These lipids, primarily unesterified cholesterol and lecithin, aggregate to form LpX. Unlike normal lipoproteins, LpX lacks Apolipoprotein B and is characterized by a high content of free cholesterol and phospholipids. It is considered a highly specific diagnostic marker for obstructive jaundice. **Why Incorrect Options are Wrong:** * **Gilbert Syndrome:** This is a benign condition characterized by unconjugated hyperbilirubinemia due to decreased bilirubin glucuronidation. It does not involve biliary obstruction or lipid regurgitation; hence, LpX is not formed. * **Trans Fatty Acids:** Increased intake of trans fats is associated with elevated LDL ("bad" cholesterol) and decreased HDL ("good" cholesterol), but it does not lead to the formation of abnormal lipoproteins like LpX. * **Polyunsaturated Fatty Acids (PUFAs):** PUFAs are generally cardioprotective and help in lowering LDL levels. They do not trigger the pathological lipid aggregation seen in cholestasis. **High-Yield Clinical Pearls for NEET-PG:** * **Composition:** LpX contains roughly 90% lipid (mostly free cholesterol and lecithin) and only 10% protein (mainly Albumin and Apo-C). * **Electrophoresis:** On agar gel electrophoresis, LpX exhibits **abnormal cathodic migration** (moves toward the cathode), which distinguishes it from other lipoproteins. * **LCAT Deficiency:** LpX is also a hallmark of Familial LCAT deficiency because the inability to esterify cholesterol leads to its accumulation in the free form, similar to the mechanism in cholestasis.

Question 482: Pancreatic secretions are a rich source of which enzyme?

A. Phospholipase A1
B. Phospholipase A2 (Correct Answer)
C. Phospholipase C
D. Phospholipase D

Explanation: **Explanation:** **Why Phospholipase A2 (PLA2) is the correct answer:** The pancreas is the primary source of digestive enzymes required for lipid breakdown in the small intestine. **Phospholipase A2** is secreted by the exocrine pancreas as a proenzyme (pro-PLA2), which is subsequently activated by trypsin in the duodenal lumen. Its primary function is to hydrolyze the ester bond at the **second carbon (C2)** of phospholipids (like lecithin), yielding a free fatty acid and a **lysophospholipid**. This process is essential for the micellar solubilization of dietary lipids. **Analysis of Incorrect Options:** * **Phospholipase A1:** This enzyme cleaves the ester bond at the first carbon (C1). While present in various mammalian tissues and some venoms, it is not a major constituent of pancreatic secretions. * **Phospholipase C:** This enzyme cleaves the bond before the phosphate group, releasing diacylglycerol (DAG) and an inositol triphosphate (IP3). It is primarily involved in **intracellular secondary messenger signaling** (G-protein coupled receptor pathways) rather than intestinal digestion. * **Phospholipase D:** This enzyme cleaves after the phosphate group, releasing phosphatidic acid. It is primarily found in plant tissues and is not a significant human digestive enzyme. **High-Yield Clinical Pearls for NEET-PG:** * **Acute Pancreatitis:** Serum levels of Phospholipase A2 are often elevated in acute pancreatitis. Excessive activation of PLA2 within the pancreas can lead to the destruction of cell membranes and parenchymal necrosis. * **Snake Venom:** The venom of many snakes (e.g., Cobras and Vipers) is rich in Phospholipase A2, which causes extensive tissue necrosis and hemolysis by damaging red blood cell membranes. * **Requirement:** Pancreatic PLA2 requires **bile salts** for optimal activity and calcium ions as a cofactor.

Question 483: Which of the following has no significant role in fat digestion?

A. Pancreatic Lipase
B. Colipase
C. Lingual lipase (Correct Answer)
D. Bile salts

Explanation: **Explanation:** The digestion of dietary lipids is a complex process primarily occurring in the small intestine. The correct answer is **Lingual Lipase** because, in healthy adults, its role is physiologically insignificant compared to pancreatic enzymes. **1. Why Lingual Lipase is the correct answer:** Lingual lipase is secreted by Ebner’s glands on the dorsal surface of the tongue. While it is acid-stable and initiates the hydrolysis of long-chain triglycerides in the stomach, it accounts for less than 10% of total lipid digestion in adults. Its contribution is considered "no significant role" because the bulk of fat digestion is handled by the pancreas. *Note: It is only significant in neonates (where pancreatic lipase is immature) or in patients with pancreatic insufficiency.* **2. Why the other options are incorrect:** * **Pancreatic Lipase (A):** This is the **primary enzyme** for fat digestion. It hydrolyzes triglycerides into 2-monoacylglycerol and free fatty acids. Without it, severe steatorrhea occurs. * **Colipase (B):** This is a crucial protein cofactor secreted by the pancreas. It binds to the water-lipid interface and anchors pancreatic lipase, preventing it from being inhibited by bile salts. * **Bile Salts (D):** These are essential for **emulsification**. They break down large fat globules into smaller droplets (micelles), increasing the surface area for lipase to act upon. **High-Yield Clinical Pearls for NEET-PG:** * **Orlistat:** An anti-obesity drug that works by inhibiting gastric and pancreatic lipases. * **Steatorrhea:** Occurs when fat malabsorption exceeds 7g/day; often due to chronic pancreatitis or biliary obstruction. * **Micelles:** Essential for the absorption of fat-soluble vitamins (A, D, E, K). * **Activation:** Pancreatic lipase is secreted in its active form, but **Colipase** is secreted as *pro-colipase* and must be activated by **Trypsin**.

Question 484: Which of the following is an essential fatty acid?

A. Linoleic acid (Correct Answer)
B. Palmitoleic acid
C. Oleic acid
D. Arachidonic acid

Explanation: **Explanation:** **1. Why Linoleic Acid is Correct:** Essential fatty acids (EFAs) are those that the human body cannot synthesize de novo because humans lack the desaturase enzymes ($\Delta^{12}$ and $\Delta^{15}$ desaturases) required to introduce double bonds beyond the $\Delta^9$ position. **Linoleic acid (18:2; $\omega$-6)** and **$\alpha$-Linolenic acid (18:3; $\omega$-3)** are the two primary EFAs. They must be obtained through the diet (e.g., vegetable oils, nuts) to support cell membrane integrity and serve as precursors for bioactive molecules. **2. Analysis of Incorrect Options:** * **Palmitoleic acid (16:1; $\omega$-7):** This is a monounsaturated fatty acid that the body can synthesize from palmitic acid via $\Delta^9$-desaturase. * **Oleic acid (18:1; $\omega$-9):** The most common dietary fatty acid (found in olive oil), it is non-essential as it is synthesized in the body from stearic acid. * **Arachidonic acid (20:4; $\omega$-6):** While often grouped with EFAs, it is technically **"conditionally essential."** It can be synthesized in the body from linoleic acid. It only becomes essential if there is a dietary deficiency of linoleic acid. **3. High-Yield Clinical Pearls for NEET-PG:** * **EFA Deficiency:** Characterized by scaly dermatitis (phrynoderma or "toad skin"), alopecia, and poor wound healing. * **Precursor Role:** Linoleic acid is the precursor for Arachidonic acid, which is the starting point for the synthesis of **prostaglandins, thromboxanes, and leukotrienes** (Eicosanoids). * **Omega Nomenclature:** Remember that $\omega$-3 ($\alpha$-Linolenic) is cardioprotective and anti-inflammatory, whereas an imbalance favoring $\omega$-6 can be pro-inflammatory.

Question 485: In fatty acid synthesis, CO2 loss occurs in which step?

A. Hydration
B. Dehydration
C. Condensation reaction (Correct Answer)
D. Reduction

Explanation: ### Explanation In fatty acid synthesis (Lipogenesis), the process occurs in the cytosol via the **Fatty Acid Synthase (FAS) multienzyme complex**. **1. Why "Condensation reaction" is correct:** The synthesis begins with the condensation of an **Acetyl group** (2C) and a **Malonyl group** (3C). This reaction is catalyzed by the enzyme *3-ketoacyl synthase*. During this step, the malonyl group undergoes **decarboxylation** (loss of $CO_2$). The energy released from this decarboxylation drives the endergonic reaction forward, allowing the two carbons of the malonyl group to attach to the growing acyl chain. Thus, while $CO_2$ is added to Acetyl-CoA to form Malonyl-CoA (via Acetyl-CoA Carboxylase), it is **lost** during the condensation step. **2. Why other options are incorrect:** * **Reduction:** There are two reduction steps in each cycle of fatty acid synthesis. These use **NADPH** as a reducing agent but do not involve $CO_2$ release. * **Dehydration:** This involves the removal of a water molecule ($H_2O$) to create a double bond (forming trans-2-enoyl-ACP); it does not involve $CO_2$. * **Hydration:** This is the reverse process (adding water), which occurs in $\beta$-oxidation (fatty acid breakdown), not synthesis. **3. High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme:** Acetyl-CoA Carboxylase (requires **Biotin**). * **Reductant source:** **NADPH** is essential, primarily supplied by the **HMP Shunt** (Pentose Phosphate Pathway). * **The "Primer":** Acetyl-CoA acts as the initial primer, but all subsequent 2-carbon units are added via **Malonyl-CoA**. * **End product:** The primary end product of the FAS complex is **Palmitate (16C)**. * **Inhibitor:** Long-chain Acyl-CoA (feedback inhibition); **Activator:** Citrate (shuttles Acetyl-CoA from mitochondria to cytosol).

Question 486: A patient presents with high LDL and increased total cholesterol, but normal levels of LDL receptors. What is the most probable cause?

A. Apo B100 mutation (Correct Answer)
B. Apo E defect
C. LCAT Deficiency
D. Lipoprotein lipase Deficiency

Explanation: **Explanation:** The correct answer is **Apo B100 mutation**. This condition is clinically known as **Familial Defective Apolipoprotein B100**. **1. Why Apo B100 mutation is correct:** Low-Density Lipoprotein (LDL) particles are cleared from the blood when the **LDL receptor (LDLR)** on the liver recognizes and binds to **Apolipoprotein B100** on the LDL surface. In this scenario, the LDL receptors are normal in number and function, but the "ligand" (Apo B100) is mutated. This structural defect prevents LDL from binding to its receptor, leading to decreased clearance and elevated plasma LDL and total cholesterol levels. This mimics the clinical presentation of Type IIa Hyperlipoproteinemia (Familial Hypercholesterolemia) but with normal receptors. **2. Why other options are incorrect:** * **Apo E defect:** Apo E is essential for the clearance of chylomicron remnants and VLDL remnants (IDL). A defect leads to **Type III Hyperlipoproteinemia** (Dysbetalipoproteinemia), characterized by elevated IDL and cholesterol/triglycerides, not isolated high LDL. * **LCAT Deficiency:** Lecithin-cholesterol acyltransferase (LCAT) is required for cholesterol esterification in HDL. Deficiency leads to **Fish-eye disease**, characterized by low HDL and corneal opacities, not high LDL. * **Lipoprotein Lipase (LPL) Deficiency:** LPL breaks down triglycerides in chylomicrons and VLDL. Deficiency causes **Type I Hyperlipoproteinemia**, leading to severe hypertriglyceridemia and eruptive xanthomas, rather than isolated hypercholesterolemia. **High-Yield NEET-PG Pearls:** * **Apo B100** is the primary structural protein of VLDL, IDL, and LDL. * **Apo B48** (found in chylomicrons) lacks the LDL-receptor binding domain found in Apo B100. * **PCSK9 inhibitors** are a modern drug class that increases LDL receptor density by preventing their degradation, used when LDL remains high despite statin therapy.

Question 487: Which of the following is not a steroid?

A. Estrogen
B. Cholic acid
C. Leukotrienes (Correct Answer)
D. Vitamin D

Explanation: ### Explanation **Why Leukotrienes are the correct answer:** Steroids are derivatives of **Cyclopentanoperhydrophenanthrene (CPPP)**, also known as the sterane nucleus. **Leukotrienes**, however, are **Eicosanoids**. They are derived from Arachidonic acid (a 20-carbon polyunsaturated fatty acid) via the Lipoxygenase (LOX) pathway. Unlike steroids, which have a four-ring fused structure, leukotrienes are linear (aliphatic) molecules and do not contain the steroid nucleus. **Analysis of Incorrect Options:** * **Estrogen:** This is a steroid hormone synthesized from cholesterol. It contains the characteristic tetracyclic steroid nucleus. * **Cholic acid:** This is a primary **bile acid**. Bile acids are end-products of cholesterol metabolism in the liver and retain the steroid nucleus (specifically the cholane structure). * **Vitamin D:** Often called a "secosteroid," Vitamin D is derived from 7-dehydrocholesterol. Although one of its rings is broken (B-ring cleavage by UV light), it is chemically classified as a steroid derivative. **High-Yield NEET-PG Pearls:** * **The Parent Molecule:** All human steroids are synthesized from **Cholesterol**. * **Leukotriene Clinical Link:** Leukotriene B4 (LTB4) is a potent chemotactic agent for neutrophils ("**B**4 attracts **B**acteria-fighters"). * **Pharmacology Tip:** Corticosteroids inhibit Phospholipase A2, thereby blocking the production of *both* Prostaglandins and Leukotrienes. In contrast, NSAIDs only block the Cyclooxygenase (COX) pathway. * **Steroid Nucleus:** Remember the name **CPPP** (Cyclopentanoperhydrophenanthrene); it is a frequent examiner favorite.

Question 488: Abetalipoproteinemia is due to deficiency of which protein?

A. Lecithin Cholesterol Acyl Transferase
B. ATP Binding Cassette Transporter-1
C. Mitochondrial Triglyceride Transfer Protein (Correct Answer)
D. ApoCII

Explanation: **Explanation:** **Abetalipoproteinemia** (Bassen-Kornzweig syndrome) is an autosomal recessive disorder caused by a mutation in the gene encoding **Mitochondrial Triglyceride Transfer Protein (MTP)**. MTP is essential for the assembly and secretion of ApoB-containing lipoproteins. It functions by loading lipids (triglycerides) onto **ApoB-48** in the enterocytes and **ApoB-100** in the hepatocytes. In its absence, Chylomicrons, VLDL, and LDL cannot be formed or secreted into the plasma, leading to near-zero levels of these lipoproteins. **Analysis of Incorrect Options:** * **Option A (LCAT):** Deficiency leads to Fish Eye Disease or Norum disease. LCAT is responsible for esterifying cholesterol within HDL. * **Option B (ABC-1):** Deficiency causes **Tangier Disease**, characterized by the inability to clear cholesterol from peripheral cells, leading to extremely low HDL levels and orange tonsils. * **Option D (ApoCII):** Deficiency causes **Type I Hyperlipoproteinemia** (Familial Chylomicronemia Syndrome) because ApoCII is a required cofactor for Lipoprotein Lipase (LPL). **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Presentation:** Malabsorption of fats, steatorrhea, and failure to thrive in infancy. * **Vitamin Deficiencies:** Severe deficiency of fat-soluble vitamins (A, D, E, K), particularly **Vitamin E**, leading to spinocerebellar degeneration and retinitis pigmentosa. * **Hematology:** Presence of **Acanthocytes** (spur cells) on peripheral blood smear due to altered RBC membrane lipid composition. * **Biopsy:** Intestinal biopsy shows lipid-laden enterocytes (vacuoles) after a fatty meal.

Question 489: To be defined as a ganglioside, a lipid substance isolated from nervous tissue must contain which of the following in its structure?

A. N-Acetylneuraminic acid (NANA), hexoses, sphingosine, long chain fatty acid (Correct Answer)
B. NANA, hexoses, a fatty acid, sphingosine, phosphorylcholine
C. NANA, sphingosine, ethanolamine
D. NANA, hexoses, fatty acid, glycerol

Explanation: ### Explanation **Concept Overview:** Gangliosides are the most complex type of **glycosphingolipids**. They are primarily found in the gray matter of the brain and at nerve endings. To be classified as a ganglioside, a molecule must possess a **Ceramide backbone** (Sphingosine + Long-chain fatty acid) attached to an oligosaccharide chain (Hexoses) that contains at least one residue of **N-Acetylneuraminic acid (NANA)**, also known as **Sialic acid**. **Why Option A is Correct:** Option A correctly identifies the four essential components: 1. **Sphingosine + Long-chain fatty acid:** Together these form Ceramide, the lipid anchor. 2. **Hexoses:** Sugars (like glucose and galactose) that form the carbohydrate head group. 3. **NANA (Sialic acid):** The defining characteristic that distinguishes gangliosides from neutral cerebrosides or globosides. **Analysis of Incorrect Options:** * **Option B:** Includes **Phosphorylcholine**. This is incorrect because phosphorylcholine is the polar head group for **Sphingomyelin**, which is a phospholipid, not a glycolipid. * **Option C:** Lacks **Hexoses** (sugars) and includes **Ethanolamine**. Ethanolamine is typically found in phospholipids like Cephalin, not gangliosides. * **Option D:** Includes **Glycerol**. Gangliosides are based on a **Sphingosine** backbone, not a glycerol backbone. Glycerol-based lipids are called glycerophospholipids. **High-Yield Clinical Pearls for NEET-PG:** * **Sialic Acid (NANA):** It provides a negative charge to the ganglioside at physiological pH. * **Tay-Sachs Disease:** Caused by a deficiency of **Hexosaminidase A**, leading to the accumulation of **GM2 ganglioside**. * **Guillain-Barré Syndrome (GBS):** Often involves the production of autoantibodies against specific gangliosides (e.g., **GM1** or **GQ1b**). * **Cholera Toxin:** The B-subunit of the *Vibrio cholerae* toxin binds specifically to the **GM1 ganglioside** on intestinal mucosal cells.

Question 490: What are lipotropic factors?

A. Choline (Correct Answer)
B. Betaine
C. Methionine
D. Tryptophan

Explanation: **Explanation:** **Lipotropic factors** are substances required for the normal mobilization of fat from the liver. Their deficiency leads to the accumulation of triglycerides, resulting in a **fatty liver**. **1. Why Choline is the Correct Answer:** Choline is the most significant lipotropic factor. It is a precursor for **Phosphatidylcholine (Lecithin)**, which is an essential component of the phospholipid shell of **Very Low-Density Lipoproteins (VLDL)**. Since triglycerides are exported from the liver primarily as VLDL, a deficiency in choline prevents VLDL assembly, trapping fat inside hepatocytes. **2. Analysis of Other Options:** * **Betaine and Methionine:** While these are technically lipotropic agents, they act indirectly. Methionine provides methyl groups to form choline, and Betaine is a metabolic product of choline. In the context of standard medical examinations, **Choline** is considered the primary/direct lipotropic factor. * **Tryptophan:** This is an essential amino acid used for the synthesis of Serotonin, Melatonin, and Niacin (Vitamin B3). It does not play a direct role in lipid mobilization or VLDL assembly. **3. NEET-PG High-Yield Clinical Pearls:** * **Mechanism:** Lipotropic factors prevent fatty liver by ensuring the synthesis of phospholipids and the subsequent export of VLDL. * **Other Lipotropic Factors:** Inositol, Vitamin E, and Selenium (antioxidants that prevent lipid peroxidation). * **Fatty Liver Causes:** Chronic alcoholism (increases NADH/NAD+ ratio), Protein Energy Malnutrition (decreased Apo-B100 synthesis), and Diabetes Mellitus. * **Key Association:** Deficiency of **Apolipoprotein B-100** also leads to fatty liver because it is the primary structural protein required for VLDL secretion.

Practice by Chapter

Lipid Classification and Chemistry

Practice Questions

Fatty Acid Oxidation

Practice Questions

Ketone Body Metabolism

Practice Questions

Fatty Acid Synthesis

Practice Questions

Metabolism of Triacylglycerols

Practice Questions

Phospholipid Metabolism

Practice Questions

Cholesterol Metabolism and Biosynthesis

Practice Questions

Bile Acids and Bile Salts

Practice Questions

Lipoprotein Metabolism and Transport

Practice Questions

Dyslipidemias and Atherosclerosis

Practice Questions

Prostaglandins and Eicosanoids

Practice Questions

Fatty Liver and Lipotropic Factors

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free